Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon
Public ClinicalTrials.gov record NCT00266669. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III "in-Life" Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, and Matching Placebo Gel in the Treatment and Prevention of Raynaud's Phenomenon
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate the efficacy and safety of a topical gel formulation of nitroglycerin, in comparison to a matching placebo, for patients with moderate to severe primary Raynaud's phenomenon or patients with Raynaud's phenomenon secondary to autoimmune diseases, such as scleroderma.
Study identification
- NCT ID
- NCT00266669
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- May 2006 (Type not available)
- Last update posted
- Aug 8, 2007
2005 – 2006
United States locations
- U.S. sites
- 17
- U.S. states
- 16
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford Medical School | Stanford | California | 94305 | — |
| University of Colorado at Denver and Health Sciences Center | Denver | Colorado | 80204 | — |
| University of Connecticut | Farmington | Connecticut | 06030 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| University of Chicago Center for Advanced Medicine | Chicago | Illinois | 60637 | — |
| Johns Hopkins Bayview Medical Center | Baltimore | Maryland | 21224 | — |
| Boston University School of Medicine | Boston | Massachusetts | 02118 | — |
| Arthritis Education & Treatment Center, PLLC | Grand Rapids | Michigan | 49546 | — |
| University of Medicine and Dentistry of New Jersey | New Brunswick | New Jersey | 08903 | — |
| The Center for Rheumatology | Albany | New York | 12206 | — |
| SUNY Stony Brook | East Setauket | New York | 11733 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Medical University of Ohio | Toledo | Ohio | 43614 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| University of Texas Medical School at Houston | Houston | Texas | 77030 | — |
| Virginia Mason Benaroya Research Institute | Seattle | Washington | 98101 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00266669, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 8, 2007 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00266669 live on ClinicalTrials.gov.